Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors

European Journal of Pharmacology

Volumn 692, Issue 1-3, 2012, Pages 69-77

  Marichal Cancino, Bruno A ^a   González Hernández, Abimael ^a   Manrique Maldonado, Guadalupe ^a   Ruiz Salinas, Inna I ^a   Altamirano Espinoza, Alain H ^a   Maassenvandenbrink, Antoinette ^b   Villalón, Carlos M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Capsaicin; CGRP; Dihydroergotamine; External carotid artery; Migraine

Indexed keywords

ACETYLCHOLINE; ALPHA CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; DIHYDROERGOTAMINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PHENYLEPHRINE; RAUWOLSCINE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL TONE; CAROTID ARTERY FLOW; COMMON CAROTID ARTERY; CONDUCTANCE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG INHIBITION; DRUG MEGADOSE; EXTERNAL CAROTID CONDUCTANCE; HEART RATE; LOW DRUG DOSE; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; THYROID ARTERY; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BLOOD CIRCULATION; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CAROTID ARTERIES; DIHYDROERGOTAMINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMICS; INJECTIONS, SPINAL; MALE; OXADIAZOLES; PIPERAZINES; PROPYLENE GLYCOL; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; VASODILATION; VASODILATOR AGENTS; YOHIMBINE;

EID: 84865862183     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.07.033     Document Type: Article

References (42)

1. S. Akerman, P. Holland, and P.J. Goadsby Diencephalic and brainstem mechanisms in migraine Nat. Rev. Neurosci. 12 2011 570 584
2. rd, and M.A. Moskowitz Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion Neuropharmacology 30 1991 1193 1200
3. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
4. D.W. Dodick Examining the essence of migraine - is it the blood vessel or the brain? A debate Headache 48 2008 661 667
5. M. Dux, P. Sántha, and G. Jancsó Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat J. Physiol. 552 2003 859 867
6. 1F receptor agonist lasmiditan - a randomised proof-of-concept trial Cephalalgia 30 2010 1170 1178
7. 3H- dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine Ann. Neurol. 29 1991 91 94
8. J.R. Graham, and H.G. Wolff Mechanisms of migraine headache and action of ergotamine tartrate Arch. Neurol. Psyquiat. 39 1938 737 763
9. (1B/1D) and CGRP receptors Pharmacol. Ther. 128 2010 170 190
10. 35S]GTPgammaS binding Biochem. Pharmacol. 55 1998 1035 1043
11. 2A/2C-adrenergic receptors Eur. J. Pharmacol. 543 2006 68 76
12. K. Kapoor, U. Arulmani, J.P.C. Heiligers, I.M. Garrelds, E.W. Willems, H. Doods, C.M. Villalón, and P.R. Saxena Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs Br. J. Pharmacol. 140 2003 329 338
13. K. Kapoor, U. Arulmani, J.P.C. Heiligers, E.W. Willems, H. Doods, C.M. Villalón, and P.R. Saxena Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig Eur. J. Pharmacol. 475 2003 69 77
14. 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain Br. J. Pharmacol. 137 2002 1287 1297
15. K.S. Kim, H.Y. Yoo, K.S. Park, J.K. Kim, Y.H. Zhang, and S.J. Kim Differential effects of acute hypoxia on the activation of TRPV1 by capsaicin and acidic pH J. Physiol. Sci. 62 2012 93 103
16. L.I. Kleinman, and E.P. Radford Ventilation standards for small mammals J. Appl. Physiol. 19 1964 360 362
17. (1B/1D) receptor agonist activity? Neuropharmacology 40 2001 520 525
18. 3H] alniditan Mol. Pharmacol. 50 1996 1567 1580
19. A.S. Link, A. Kuris, and L. Edvinsson Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system J. Headache Pain 9 2008 5 12
20. M.A. Moskowitz, J.F. Reinhard Jr., J. Romero, E. Melamed, and D.J. Pettibone Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet 2 1979 883 885
21. 1D receptors Br. J. Pharmacol. 149 2006 82 91
22. 1D receptors Eur. J. Pharmacol. 615 2009 133 138
23. K. Nozaki, M.A. Moskowitz, and P. Boccalini CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges Br. J. Pharmacol. 106 1992 409 415
24. J. Olesen, R. Burstein, M. Ashina, and P. Tfelt-Hansen Origin of pain in migraine: evidence for peripheral sensitisation Lancet Neurol. 8 2009 679 690
25. 1B/1D receptor antagonist GR127935 CNS Drug Rev. 2 1996 415 428
26. 1D receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 356 1997 312 320
27. K. Saito, S. Markowitz, and M.A. Moskowitz Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches Ann. Neurol. 24 1988 732 737
28. J.R. Saper, and S. Silberstein Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine Headache 46 2006 S171 S181
29. P.R. Saxena, and G.M. de Vlaam-Schluter Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine - studies in an experimental model for migraine Headache 13 1974 142 163
30. E. Shevel The extracranial vascular theory of migraine - a great story confirmed by the facts Headache 51 2011 409 417
31. E. Shevel The extracranial vascular theory of migraine: an artificial controversy J. Neural Transm. 118 2011 525 530
32. 2C adrenergic receptors J. Pharmacol. Exp. Ther. 271 1994 1558 1565
33. C.M. Villalón, D. Centurión, L.F. Valdivia, P. De Vries, and P.R. Saxena Migraine: pathophysiology, pharmacology, treatment and future trends Curr. Vasc. Pharmacol. 1 2003 71 84
34. 2A/2C-adrenergic receptors mediate external carotid vasoconstriction to dihydroergotamine Eur. J. Pharmacol. 484 2004 287 290
35. 2-adrenergic receptors Br. J. Pharmacol. 126 1999 585 594
36. 2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation Eur. J. Pharmacol. 683 2012 204 210
37. C.M. Villalón, and J. Olesen The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs Pharmacol. Ther. 124 2009 309 323
38. C.M. Villalón, E. Ramírez-San Juan, C. Castillo, F.J. López-Muñoz, and J.A. Terrón Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs Br. J. Pharmacol. 116 1995 2778 2784
39. 1-like receptors in the increase in external carotid blood flow induced by 5-hydroxytryptamine in the dog Eur. J. Pharmacol. 240 1993 9 20
40. Y. Wang, R. Aun, and L.S.F. Tse Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat Biopharm. Drug Dispos. 19 1998 571 575
41. 2-adrenergic receptor subtypes mediating vasoconstriction in the canine external carotid circulation Br. J. Pharmacol. 132 2001 1292 1298
42. T.L. Yaksh, K.A. Horais, N. Tozier, M. Rathbun, P. Richter, S. Rossi, M. Grafe, C. Tong, C. Meschter, J.M. Cline, and J. Eisenach Intrathecal ketorolac in dogs and rats Toxicol. Sci. 80 2004 322 334